halt probably Wm not ci ienobiotic fegotoc* agents in the environment. However, with an adeq battery ofnecf expsre blmarkers, prospective studies of environmental effects on pregnancy outcomes might be possible. lb narrow the lst of potentil exposures, these prospective studies could be foLowed by case-cntrol studies of more specific blomarks dired at upect exposures.
Introduction
The researchofHatch (1) Using questionnaires to assess the extent of an individual's potential for exposure may help to reduce misclassification bias. Yet reports of individual exposures can be erroneous in either direction (4) . In addition, people are often unaware of their potential for exposure, and researchers may not know or be able to account for all the pathways ofexposure. For example, certain mothers in a Yugoslav community with a lead smelter had elevated blood-lead levels. Questionnaire data detennined which ofthese women were wives ofmen employed in the lead industry. However, these data could not distinguish between women with low blood-lead levels and women with elevated levels (4). In this example, a biological exposure marker (blood lead-level) was available for classifying mothers according to their exposure to lead. To date, such biological markers have not been widely available nor have they been widely used when they are available.
Several years ago, the Environmental Protection Agency cosponsored a National Research Council study on The Role of Biomarkers in Reproductive and Developmental Toxicology (5).
2HOGUEAND BREWSYER
After reviewing the situation, Longo described a "paradox" (6) . Although several techniques for identifying individual exposures have been developed and tested, and although more and more xenobiotics have been recognized to have teratogenic and mutagenic potential, "essentially no specific biomarkers are currently available to indicate that exposure to a given xenobiotic is directly associated with a cellular, subcellular, or pharmacodynamic event" (6) . The paradox continues, despite continuing advancements in laboratory science and the growing recognition of the need for biological markers to improve exposure measurement in the field ofenvironmental epidemiology (3, 4, (7) (8) (9) . To further the development and application ofexposure markers in studying the environmental hazards to reproductive health, we have attempted to synthesize recent examinations of the issues surrounding exposure measurements in reproductive epidemiology. The specific goals ofthis paper are to explore the potential uses ofbiomarkers as measures ofexposure, particularly as they may be used in an environmental setting as screening tools. (2) .
Biomarkers
Internal dose-exposure markers may be useful to improve the quality ofexposure measurement in an epidemiologic investigation ofa known environmental hazard; to serve as the "gold standard" for other infrmation sources; to provide a screening tool for environmental exposures to a target tissue (in this case, the fetus); and to provide quantification ofthe biological load from a known exposure (4). To be useful in epidemiologic investigations of reproductive health an exposure marker should be better than the woman's ability to recall an exposure; allow for differentiation between exposure levels, at least qualitatively; allow the use ofnoninvasive procedures that are applicable on a large scale; and provide interprable data for short-term or cumulative exposure regarding time, dose, and duration (4) .
For the environmental Sherlock Holmes, internal dose markers offer strong circumstantial evidence that the perpetator xenobiotic has invaded the human victim. This evidence is very specific if the chemical is retrieved unaltered. However, substantial circumstantial evidence can be gleaned from metabolically altered chemicals. The metabolic outcome can be very specific (e.g., urinary cotinine for nicotine in cigarette smoke) or nonspecific (e.g., thioethers for cigarette smoking).
Nonspecific markers measure a biochemical pathway affected by a variety of xenobiotic agents.
Exposure Markers As Screening Tools
In addition to possessing the characteristics of all useful exposure markers, biomarkers used as exposure screens should be able to detect subtoxic exposures and be nonspecific (8) . Nonspecificity ofthe marker is important because the environment commonly includes complex and unknown chemical mixtures, such as those found in drinking water, that could be misclassified by selecting a few specific markers for a screening battery.
For epidemiologic research, nonspecific markers tend to be held in lower esteem than specific markers, since it is impossible, without further evidence, to identify which chemical has triggered the metabolic response being measured. However, as screening tools, nonspecific markers hold some promise. A biomarker that can be used to detect that one or more ofa class of xenobiotic agents to which the pregnant woman has been exposed and may have exposed her fetus could be useful for targeting a subset of women for further investigation and follow-up. First, however, the fiat that the metabolic pathway has been altered must be correlated with adverse human reproductive outcomes so that such alteration can be shown to reflect fetotoxicity.
We have previously proposed three nonspecific urinary biomarkers as potential screening tools for reproductive epidemiology (8) investigators. i00 studies were positive for altered mutagenicity (13, 17) , but two later reports were negative (25, 42) . This difference may reflect changes in routines for handling these drugs. 
Porphyrins
Urinary porphyrin patterns are assessable through automated laboratory methods using high-pressure liquid chromatography (105) . Brewster (9) has reviewed the usefulness ofmeasuring total urine porphyrins to detect xenobiotic exposures to heavy metals, hormones, drugs, and halogenated aromatic hydrocarbons. These chemicals induce chronic disturbances in hepatic synthesis ofporphyrins (Tible 4) and thus lead to excess porphyrin excretion and skin symptoms in the final stage (107) (108) (109) (110) (111) (112) (113) (114) (115) (116) (117) (118) (119) (120) (121) (122) (123) (124) .
Presumably, all xenobiotics dtat produce chronic changes would also show the urinary patten at early stages prior to overt toxicity, but this assumption has not been tested in all circumstances.
Strengths and Limitations of Proposed Screening Battery
These four tests discussed previously generally meet the criteria for useful exposure screens. For certain xenobiotic agents, they accurately differentiate exposure levels, as demonstrated in occupational and environmental epidemiologic studies. As urinary screens, they are noninvasive and applicable on a large scale with current laboratory techniques. For First, tests must be standardized for pregnant women. Although there is little evidence to suggest that pregnancy itself can alter these test outcomes, it is important to establish standard levels for pregnant women with normal pregnancy outcomes. Second, tests should be administered to women with known exposures, such as maternal smoking, so that patterns ofalterations can be correlated with reported exposures. Third, the tests must be associated with adverse pregnancy outcomes, such as reduced birthweight or gestational length. This last element in the validation research is particularly important since maternal exposure rather than fetal exposure is being measured. The extent to which xenobiotic chemicals cross the placental barrier may vary greatly, depending on the type ofexposures, timing in pregnancy, and maternal detoxification capability. Ifthe battery ofscreening tests proves useful, further field investigations would be warranted to determine the tests' ability to measure environmental exposures that adversely affect fetal development.
In reproductive epidemiology, we may be at a unique point for implementing this validation process. Because a number of studies of early pregnancy loss are collecting serial urines during pregnancy, the moment may be opportune to begin examining these urines for metabolic alterations, as tests of the potential usefulness ofthese nonspecific biomarkers to predict adverse pregnancy outcomes. Progress is being made in learning about these tests' response to specific environmental chemicals, but more research needs to focus on the quantitative relationship of these agents to body burdens. It would be helpful if this battery oftests were routinely applied to pregnant women in known exposure situations. Also, ifpregnant wvmen with abnormal tests (with and without adverse outcomes) were investigated further, much could be learned about the metabolic functions that are affected and the specific chemicals that are creating the effect.
Conclusion
Without better exposure measures, epidemiologic studies of reproduction will probably fail to identify xenobiotic fetotoxic agents in the environment. However, with an adequate battery of nonspecific exposure biomarkers, prospective studies of environmental effects on pregnancy outcomes might be possible. A proposed battery of nonspecific biomarkers should be tested to determine their usefulness for predicting adverse pregnancy outcomes.
